You just read:

Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis-associated Small Fiber Neuropathy

News provided by

Araim Pharmaceuticals, Inc.

Oct 28, 2014, 09:10 ET